Patents Assigned to Aria Diagnostics, Inc.
  • ASSAY SYSTEMS FOR GENETIC ANALYSIS
    Publication number: 20130090250
    Abstract: The present invention provides assays systems and methods for detection of chromosomal abnormalities and status of single loci associated with monogenic or polygenic traits in a sample containing nucleic acids from a maternal and a fetal source.
    Type: Application
    Filed: November 28, 2012
    Publication date: April 11, 2013
    Applicant: ARIA DIAGNOSTICS, INC.
    Inventor: ARIA DIAGNOSTICS, INC.
  • DETECTION OF GENETIC ABNORMALITIES
    Publication number: 20120190021
    Abstract: The present invention provides assay systems and related methods for determining genetic abnormalities in mixed samples comprising cell free DNA from both normal and putative genetically atypical cells. Exemplary mixed samples for analysis using the assay systems of the invention include samples comprising both maternal and fetal cell free DNA and samples that contain DNA from normal cells and circulating cancerous cells.
    Type: Application
    Filed: January 23, 2012
    Publication date: July 26, 2012
    Applicant: Aria Diagnostics, Inc.
    Inventors: Arnold Oliphant, Andrew Sparks, Ken Song, John Stuelpnagel
  • RISK CALCULATION FOR EVALUATION OF FETAL ANEUPLOIDY
    Publication number: 20120191358
    Abstract: The present invention provides processes for determining accurate risk probabilities for fetal aneuploidies. Specifically, the invention provides non-invasive evaluation of genomic variations through chromosome-selective sequencing and non-host fraction data analysis of maternal samples.
    Type: Application
    Filed: December 28, 2011
    Publication date: July 26, 2012
    Applicant: Aria Diagnostics, Inc.
    Inventors: Arnold Oliphant, Andrew Sparks, Eric Wang, Craig Struble
  • RISK CALCULATION FOR EVALUATION OF FETAL ANEUPLOIDY
    Publication number: 20120190557
    Abstract: The present invention provides processes for determining accurate risk probabilities for chromosome dosage abnormalities. Specifically, the invention provides non-invasive evaluation of genomic variations through chromosome-selective sequencing and non-host fraction data analysis of maternal samples.
    Type: Application
    Filed: December 9, 2011
    Publication date: July 26, 2012
    Applicant: Aria Diagnostics, Inc.
    Inventors: Arnold Oliphant, Andrew Sparks, Eric Wang, Craig Struble
  • DETECTION OF GENETIC ABNORMALITIES
    Publication number: 20120190020
    Abstract: The present invention provides assay systems and related methods for determining genetic abnormalities in mixed samples comprising cell free DNA from both normal and putative genetically atypical cells. Exemplary mixed samples for analysis using the assay systems of the invention include samples comprising both maternal and fetal cell free DNA and samples that contain DNA from normal cells and circulating cancerous cells.
    Type: Application
    Filed: January 23, 2012
    Publication date: July 26, 2012
    Applicant: Aria Diagnostics, Inc.
    Inventors: Arnold Oliphant, Andrew Sparks, Ken Song, John Stuelpnagel